Slow-release oral morphine for opioid maintenance treatment: a systematic review.
This review article summarizes the results of all available clinical trials considering the use of slow-release oral morphine (SROM) for opioid maintenance treatment (OMT). All studies published up to October 2010 and assessing SROM for OMT in adult patients are included. Three independent reviewers assessed the selected articles using a standardized checklist. Study design, study length and number of subjects included were recorded. Data about retention rate (proportion of participants remaining under maintenance treatment at the end of the study), quality of life, withdrawal symptoms, craving, additional drug consumption, driving capacity and adverse events were collected. We identified 13 articles corresponding to nine clinical trials considering the use of SROM for OMT. Among them, only one was a randomized trial and one was a controlled not randomized trial. All other studies were uncontrolled. Retention rates were good (from 80.6 to 95%) with SROM maintenance, but similar retention rates were obtained with methadone. Most of the studies showed that quality of life, withdrawal symptoms, craving and additional drug consumption improved with SROM. However, there was no comparison with other maintenance drugs. As most of the studies assessing SROM efficacy were uncontrolled, there is no definite evidence that SROM is an effective alternative to methadone for OMT.
Department of Medical and Clinical Pharmacology, Centre d'Evaluation et d'Information sur Pharmacodépendance Addictovigilance, University Hospital of Toulouse, 31000 Toulouse, France. jeremie.jegu@unistra.fr
Jeremie
J
Jegu
Adeline
A
Gallini
Pauline
P
Soler
Jean-Louis
JL
Montastruc
Maryse
M
Lapeyre-Mestre
D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D006801:Humans; D009020:Morphine / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy / Q000534:rehabilitation*; D016032:Randomized Controlled Trials as Topic; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000534:rehabilitation*; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D009020:Morphine
Addiction. 1994 Nov;89(11):1565-9
7841872
Cochrane Database Syst Rev. 2002;(2):CD002210
12076441
Med J Aust. 1996 Aug 19;165(4):239
8773665
Intern Med J. 2010 Jan;40(1):88-9
20561375
Am J Addict. 2006 Jul-Aug;15(4):311-5
16867927
Addiction. 2003 Apr;98(4):441-52
12653814
Wien Klin Wochenschr. 2002 Nov 30;114(21-22):904-10
12528322
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD002207
18425880
N Engl J Med. 2000 Nov 2;343(18):1290-7
11058673
Addiction. 2005 Aug;100(8):1101-9
16042640
Addiction. 2005 Jul;100(7):1027
15955021
Addiction. 2009 Sep;104(9):1549-57
19686525
Ann Med Interne (Paris). 2002 May;153(3 Suppl):1S20-6
12218879
West J Med. 2000 Jan;172(1):26
18751211
Epidemiology. 2007 Nov;18(6):805-35
18049195
Subst Use Misuse. 2006;41(2):223-44
16393744
Acta Psychiatr Scand. 1990 Sep;82(3):223-7
2248048
Eur Addict Res. 2006;12(2):53-60
16543739
Eur Addict Res. 2005;11(3):145-51
15990432
Ann Intern Med. 2009 Aug 18;151(4):W65-94
19622512
Addiction. 1999 Feb;94(2):231-9
10396791
Eur J Clin Pharmacol. 2010 Jun;66(6):537-45
20169438
Drug Alcohol Depend. 2003 Oct 24;72(1):85-94
14563546
Addiction. 2004 Aug;99(8):940-5
15265090
Ann Intern Med. 2001 Apr 17;134(8):663-94
11304107
Neuropsychiatr. 2010;24(2):108-17
20605006
Addiction. 2008 Nov;103(11):1837-46
19032534
Therapie. 2003 Mar-Apr;58(2):123-5
12942851
Forensic Sci Int. 2005 Sep 10;152(2-3):323-4
15921868
Eur Addict Res. 2008;14(2):99-105
18334820